| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0008 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |